Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06209216 · ClinicalTrials.gov registry record
Twenty-Four Seven Functional Status in Total Hip Replacement
A clinical trial, sponsored by Koneksa Health.
- Completed
- Registry status
- 24
- Enrollment target
NCT06209216: Completed study, sponsored by Koneksa Health.
NCT06209216 is a clinical trial that has completed, run by Koneksa Health. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06209216 has completed, sponsored by Koneksa Health.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
The goal of this observational study is to define digital remote monitoring measures for functional status (activities of daily living) in patients receiving total hip replacement. Functional status will be collected using a study iPhone and two wearable wrist monitors.
Primary Outcome
Harris Hip Score
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2023-12-13 |
| Est. Completion | 2024-10-07 |
What the finished NCT06209216 record still lists
NCT06209216 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT06209216 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06209216 about?
NCT06209216 is a clinical study titled "Twenty-Four Seven Functional Status in Total Hip Replacement". The goal of this observational study is to define digital remote monitoring measures for functional status (activities of daily living) in patients receiving total hip replacement. Functional status will be collected using a study iPhone and two wearable wrist monitors.
What is the current status of trial NCT06209216?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2023-12-13. Estimated completion is 2024-10-07.
Who is sponsoring clinical trial NCT06209216?
This trial is sponsored by Koneksa Health, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI